Proposed outcome measures for prospective clinical trials in juvenile idiopathic arthritis–associated uveitis: A consensus effort from the multinational interdisciplinary working group for uveitis in childhood

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Arthritis care & research

• Publication date

  2012-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/acr.21674PMID 22438273
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Outcome measures in JIA associated uveitis

  2011cited by this paper
• Development of a vision‐related quality of life instrument for children ages 8–18 years for use in juvenile idiopathic arthritis–associated uveitis

  2011cited by this paper
• Using the Delphi Technique to Determine Which Outcomes to Measure in Clinical Trials: Recommendations for the Future Based on a Systematic Review of Existing Studies

  2011cited by this paper
• Interobserver agreement in grading activity and site of inflammation in eyes of patients with uveitis.

  2008cited by this paper
• Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss.

  2007influential reference
• OMERACT: An international initiative to improve outcome measurement in rheumatology

  2007cited by this paper
• Risk factors for the development of cataract requiring surgery in uveitis associated with juvenile idiopathic arthritis.

  2007cited by this paper
• Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines.

  2007cited by this paper
• Maculopathy in uveitis of juvenile idiopathic arthritis: an optical coherence tomography study

  2007cited by this paper
• A reconsideration of anterior chamber flare and its clinical relevance for children with chronic anterior uveitis (an American Ophthalmological Society thesis).

  2007influential reference
• Risk factors for ocular complications and poor visual acuity at presentation among patients with uveitis associated with juvenile idiopathic arthritis.

  2007cited by this paper
• Incidence and outcomes of uveitis in juvenile rheumatoid arthritis, a synthesis of the literature

  2006influential reference
• Ocular hypertension and secondary glaucoma in children with uveitis.

  2006cited by this paper
• Identification and impact of outcome selection bias in meta‐analysis

  2005cited by this paper
• Laser flare-cell photometry: methodology and clinical applications.

  2005cited by this paper
• Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop.

  2005influential reference
• [Vision-threatening complications in childhood uveitis].

  2005cited by this paper
• A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis.

  2005cited by this paper
• Visusmindernde Komplikationen bei Uveitis im Kindesalter

  2005cited by this paper
• Analysis of pediatric uveitis cases at a tertiary referral center.

  2005cited by this paper
• The Pediatric Rheumatology International Trials Organization criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: prospective validation of the disease activity core set.

  2005cited by this paper
• Development of an instrument to assess vision-related quality of life in young children.

  2004cited by this paper
• Comparison of preschool vision screening tests as administered by licensed eye care professionals in the Vision In Preschoolers Study.

  2004cited by this paper
• Incidence of juvenile idiopathic arthritis in the Nordic countries. A population based study with special reference to the validity of the ILAR and EULAR criteria.

  2003cited by this paper
• Visual loss associated with pediatric uveitis in english primary and referral centers.

  2003cited by this paper
• Recent advances in uveitis of juvenile idiopathic arthritis.

  2003cited by this paper
• Visual loss in uveitis of childhood

  2003cited by this paper
• An evaluation of baseline risk factors predicting severity in juvenile idiopathic arthritis associated uveitis and other chronic anterior uveitis in early childhood

  2002cited by this paper
• Worldwide prevalence of juvenile arthritis why does it vary so much?

  2002cited by this paper
• PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations.

  2001cited by this paper
• Construct validity of ILAR and EULAR criteria in juvenile idiopathic arthritis: a population based incidence study from the Nordic countries. International League of Associations for Rheumatology. European League Against Rheumatism.

  2001cited by this paper
• Cross-cultural adaptation and psychometric evaluation of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ) in 32 countries. Review of the general methodology.

  2001cited by this paper
• Is fibromyalgia a generalized reflex sympathetic dystrophy?

  2001cited by this paper
• Uveitis as a cause of visual loss in arthritides and comparable conditions.

  2001cited by this paper
• Uveitis in children: population-based study in Finland.

  2000cited by this paper
• Visual outcomes prognosticators in juvenile rheumatoid arthritis-associated uveitis.

  1997cited by this paper
• The Lens Opacities Classification System III

  1993cited by this paper
• The Lens Opacities Classification System III. The Longitudinal Study of Cataract Study Group.

  1993cited by this paper
• Prognostic factors in the uveitis of juvenile rheumatoid arthritis.

  1987cited by this paper
• Group Techniques for Program Planning: A Guide to Nominal Group and Delphi Processes

  1976cited by this paper
• Academic Editor: David Moher, Children’s Hospital of Eastern

  year unknowncited by this paper

• Systemic Immunomodulatory Therapy, Anterior Chamber Inflammation, and the Use of Topical Corticosteroids in Juvenile Idiopathic Arthritis-Associated Uveitis: A Long-Term Real-Life Observational Study

  2026influential citation
• Development of a core outcome set for patients with epiretinal membranes: a Delphi consensus study

  2025cites this paper
• Comment on: Predictors of lack of response to methotrexate in juvenile idiopathic arthritis associated uveitis. Reply.

  2025cites this paper
• Monitoring of Juvenile Idiopathic Arthritis–Associated Uveitis in Long‐Term Disease Remission: Consensus‐Based Recommendations From the Multinational Interdisciplinary Working Group for Uveitis in Childhood

  2025cites this paper
• Course of uveitis in children with juvenile idiopathic arthritis (JIA): Five years follow-up data from a prospective multicenter Inception Cohort of Newly diagnosed patients with JIA (ICON-JIA) study

  2025cites this paper
• Predictors of lack of response to methotrexate in juvenile idiopathic arthritis associated uveitis

  2024cites this paper
• Encouraging visual outcomes in children with idiopathic and JIA associated uveitis: a population-based study

  2023cites this paper
• Pediatric Rheumatology Care and Outcomes Improvement Network's Quality Measure Set to Improve Care of Children With Juvenile Idiopathic Arthritis

  2023cites this paper
• Improved clinical outcomes in patients with juvenile idiopathic arthritis associated uveitis in the last decade

  2022influential citation
• Identifying common health indicators from paediatric core outcome sets: a systematic review with narrative synthesis using the WHO International Classification of Functioning, Health and Disability

  2022cites this paper
• Core Outcome Sets in Child Health: A Systematic Review.

  2022cites this paper
• New and Updated Recommendations for the Treatment of Juvenile Idiopathic Arthritis–Associated Uveitis and Idiopathic Chronic Anterior Uveitis

  2022influential citation
• Outcome selection for tissue-agnostic drug trials for immune-mediated inflammatory diseases: a systematic review of core outcome sets and regulatory guidance

  2022influential citation
• Development of a Core Outcome Set for Clinical Trials in Non-infectious Uveitis of the Posterior Segment.

  2021cites this paper
• Recommendations for the management of childhood juvenile idiopathic arthritis‐type chronic anterior uveitis

  2021cites this paper
• Diagnosis and treatment of uveitis associated with juvenile idiopathic arthritis

  2021cites this paper
• Adalimumab in the treatment of pediatric patients with chronic noninfectious anterior uveitis

  2021cites this paper
• Core Outcome Sets for Medium-Chain Acyl-CoA Dehydrogenase Deficiency and Phenylketonuria

  2021cites this paper
• Pediatric uveitis: A comprehensive review.

  2021cites this paper
• Structural Endpoints and Outcome Measures in Uveitis

  2021cites this paper
• Efficacy and Safety of Anti-TNFα Therapy for Uveitis Associated with Juvenile Idiopathic Arthritis: A Systematic Review and Meta-Analysis

  2021cites this paper
• Patient-Reported Outcome Measures in Core Outcome Sets targeted overlapping domains but through different instruments.

  2021cites this paper
• Recent advances in the treatment of juvenile idiopathic arthritis–associated uveitis

  2021cites this paper
• Biomarkers of Response to Biologic Therapy in Juvenile Idiopathic Arthritis

  2021cites this paper
• The Delphi method in rheumatology research: are we doing it right?

  2020cites this paper
• What really matters in pediatric chronic pain rehabilitation? Results of a multi-stakeholder nominal group technique study

  2020cites this paper
• Retinal Manifestations of the Rheumatic Diseases

  2020cites this paper
• Recommendations for the Management of Uveitis Associated With Juvenile Idiopathic Arthritis: The Czech and Slovak adaptation of SHARE Initiative.

  2020cites this paper
• Assessing the Validity and Reliability of the Effects of Youngsters’ Eyesight on Quality of Life Questionnaire Among Children With Uveitis

  2020cites this paper
• Quiescence and Subsequent Anterior Chamber Inflammation in Adalimumab-treated Pediatric Noninfectious Uveitis

  2020cites this paper
• Update on noninfectious uveitis in children and its treatment.

  2020cites this paper
• Using collaborative logic analysis evaluation to test the program theory of an intensive interdisciplinary pain treatment for youth with pain‐related disability

  2020cites this paper
• Pediatric uveitis: EYE-Q and metrics beyond visual acuity

  2020cites this paper
• El método Delphi en la investigación en reumatología: ¿lo estamos haciendo bien?

  2020cites this paper
• Visual Function And Quality Of Life In A Cohort Of Swedish Children With Juvenile Idiopathic Arthritis

  2019cites this paper
• Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans for Juvenile Idiopathic Arthritis–Associated and Idiopathic Chronic Anterior Uveitis

  2019cites this paper
• Update of the evidence based, interdisciplinary guideline for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis.

  2019cites this paper
• The use of patient-reported outcome research in modern ophthalmology: impact on clinical trials and routine clinical practice

  2019cites this paper
• Under-utilisation of reproducible, child appropriate or patient reported outcome measures in childhood uveitis interventional research

  2019cites this paper
• Defining outcome measures in juvenile idiopathic arthritis associated uveitis by a systematic review analysis: do we need a consensus?

  2019influential citation
• Proposal for a definition for response to treatment, inactive disease and damage for JIA associated uveitis based on the validation of a uveitis related JIA outcome measures from the Multinational Interdisciplinary Working Group for Uveitis in Childhood (MIWGUC)

  2019cites this paper
• Juvenile idiopathic arthritis-associated uveitis: a retrospective analysis from a centre of South Italy

  2019cites this paper
• OPTH_A_202486 2081..2091

  2019cites this paper
• Juvenile idiopathic arthritis-associated uveitis.

  2019cites this paper
• The enigma of uveitis in juvenile idiopathic arthritis : Genetic, immunologic and clinical aspects

  2018cites this paper
• Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative

  2018influential citation
• Komorbiditäten bei Kindern und Jugendlichen mit juveniler idiopathischerArthritis

  2018cites this paper
• Adalimumab for childhood onset uveitis

  2018cites this paper
• Predictive factors and biomarkers for the 2-year outcome of uveitis in juvenile idiopathic arthritis: data from the Inception Cohort of Newly diagnosed patients with Juvenile Idiopathic Arthritis (ICON-JIA) study

  2018cites this paper
• Comparison of Clinical Trial and Systematic Review Outcomes for the 4 Most Prevalent Eye Diseases

  2017cites this paper
• ADJUVITE: a double-blind, randomised, placebo-controlled trial of adalimumab in early onset, chronic, juvenile idiopathic arthritis-associated anterior uveitis

  2017cites this paper
• Ocular Hypotony in Patients With Juvenile Idiopathic Arthritis-Associated Uveitis.

  2017cites this paper
• Adalimumab in the Treatment of Uveitis in Juvenile Idiopathic Arthritis.

  2017cites this paper
• Uveitis in Children

  2017cites this paper
• Evidence for Updating the Core Domain Set of Outcome Measures for Juvenile Idiopathic Arthritis: Report from a Special Interest Group at OMERACT 2016

  2017cites this paper
• Juvenile idiopathic arthritis-associated uveitis.

  2017cites this paper
• Which outcomes are most important to people with aphasia and their families? an international nominal group technique study framed within the ICF

  2017cites this paper
• Cross sectional, qualitative thematic analysis of patient perspectives of disease impact in juvenile idiopathic arthritis-associated uveitis

  2017cites this paper
• Adalimumab for the treatment of refractory noninfectious paediatric uveitis

  2017influential citation
• Biomarkers and Surrogate Endpoints in Uveitis: The Impact of Quantitative Imaging.

  2017cites this paper
• Uveitis bei juveniler idiopathischer Arthritis

  2017cites this paper
• “The patient is speaking”: discovering the patient voice in ophthalmology

  2017cites this paper
• Juvenile idiopathic arthritis-associated uveitis

  2016cites this paper
• Managing juvenile idiopathic arthritis-associated uveitis.

  2016cites this paper
• Evidence for Tocilizumab as a Treatment Option in Refractory Uveitis Associated with Juvenile Idiopathic Arthritis

  2016cites this paper
• Chronic Non-infectious Uveitis in Patients with Juvenile Idiopathic Arthritis

  2016cites this paper
• Uveitis in children

  2016cites this paper
• Current Treatment Modalities of JIA-associated Uveitis and its Complications: Literature Review

  2016cites this paper
• Discontinuation of long-term adalimumab treatment in patients with juvenile idiopathic arthritis-associated uveitis

  2016cites this paper
• Development of an activity disease score in patients with uveitis (UVEDAI)

  2016cites this paper
• Managing uveitis in patients with juvenile idiopathic arthritis

  2016cites this paper
• Abatacept in the Treatment of Severe, Longstanding, and Refractory Uveitis Associated with Juvenile Idiopathic Arthritis

  2015cites this paper
• Patient-reported outcomes in core domain sets for rheumatic diseases

  2015cites this paper
• The Future Is Now: Biologics for Non-Infectious Pediatric Anterior Uveitis

  2015cites this paper
• Clinical management algorithm of uveitis associated with juvenile idiopathic arthritis: interdisciplinary panel consensus

  2015cites this paper
• Elevated S100A8/A9 and S100A12 Serum Levels Reflect Intraocular Inflammation in Juvenile Idiopathic Arthritis-Associated Uveitis: Results From a Pilot Study.

  2015cites this paper
• Uveitis associated with juvenile idiopathic arthritis

  2015cites this paper
• Uveitis in Juvenile Idiopathic Arthritis: Recent Therapeutic Advances

  2015cites this paper
• Uveitis in juvenile idiopathic arthritis.

  2015cites this paper
• Ocular Involvement in Juvenile Idiopathic Arthritis: Classification and Treatment

  2015cites this paper
• Quality-of-Life Metrics in Pediatric Uveitis

  2015cites this paper
• Does switching anti-TNFα biologic agents represent an effective option in childhood chronic uveitis: the evidence from a systematic review and meta-analysis approach.

  2014cites this paper
• Non-anti TNF biologic modifier drugs in non-infectious refractory chronic uveitis: the current evidence from a systematic review

  2014cites this paper
• Treatment of Uveitis Associated with Juvenile Idiopathic Arthritis

  2014cites this paper
• Methodology of clinical trials for rare diseases.

  2014cites this paper
• Immunomodulatory therapy with tumour necrosis factor α inhibitors in children with antinuclear antibody-associated chronic anterior uveitis: long-term results

  2014cites this paper
• Body experiences, emotional competence, and psychosocial functioning in juvenile idiopathic arthritis

  2013cites this paper
• PReS-FINAL-2063: Proposed criteria for activity, damage and impact of juvenile idiopathic arthritis associated uveitis: consensus effort from the multinational interdisciplinary working group for uveitis in childhood (MIWGUC)

  2013cites this paper
• Review for Disease of the Year: Epidemiology of Juvenile Idiopathic Arthritis and its Associated Uveitis: The Probable Risk Factors

  2013cites this paper
• Updates on the risk markers and outcomes of severe juvenile idiopathic arthritis-associated uveitis.

  2013cites this paper
• [Juvenile idiopathic arthritis].

  2005cites this paper
• Juvenile Idiopathic arthritis and glaucoma

  year unknowncites this paper
• Update of the evidence based, interdisciplinary guideline for anti-in fl ammatory treatment of uveitis associated with juvenile idiopathic arthritis Seminars in Arthritis and Rheumatism

  year unknowncites this paper